Target intelligence / Profile preview

Viral RNA replication and translation machinery (RTC)

Target
RTC
Molecular classification
Enzyme, Other
01

Overview

The viral RNA replication and translation machinery is a multi-component assembly of viral proteins and co-opted host factors essential for the life cycle of RNA viruses (Subissi et al., 2014, Nature Reviews Microbiology). At its core is the RNA-dependent RNA polymerase (RdRp), which works in tandem with helicases, exonucleases, and proteases to replicate the viral genome and transcribe messenger RNA (Hillen et al., 2020, Nature). This machinery also facilitates the hijacking of host ribosomes and translation initiation factors to ensure the preferential synthesis of viral proteins over host proteins (Walsh & Mohr, 2011, Nature Reviews Microbiology). Because many components of this machinery, such as the RdRp, have no functional equivalents in human cells, they serve as high-priority targets for broad-spectrum and virus-specific antivirals (Pruijssers & Denison, 2019, Current Opinion in Virology). Drugs like remdesivir and sofosbuvir act as nucleoside analogs that incorporate into the growing RNA strand, causing premature termination of the replication process (Gordon et al., 2020, Nature). However, the high error rate of viral replication often leads to the emergence of resistant mutations, posing a significant challenge for long-term therapeutic efficacy (Agostini et al., 2018, mBio).

Other names
Replication-transcription complexViral replicase complexViral replication machineryRNA-dependent RNA polymerase complex
02

Mechanism of action

Inhibition of RNA-dependent RNA polymerase (RdRp) leading to chain termination or lethal mutagenesis; inhibition of viral proteases to prevent polyprotein cleavage; interference with viral RNA capping and translation initiation.

03

Biological functions

OtherImmune response
04

Disease associations

Infection
05

Safety considerations

Mitochondrial toxicity due to host polymerase inhibitionTeratogenicity and mutagenicityRapid emergence of drug-resistant viral variantsOff-target effects on host translation machinery
06

Interacting drugs

Remdesivir

7 more in the full profile.

07

Biomarkers

Viral load (RT-qPCR)Viral RNA titersViral protein expression (e.g., NS3, NS5A, N-protein)Serum transaminase levels

Beyond the preview

Go deeper on Viral RNA replication and translation machinery (RTC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Viral RNA replication and translation machinery (RTC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call